Rossi et al. reported that HBME-1 alone and combined with galectin-3 and CK19 can help to make the correct distinction between malignant and benign thyroid neoplasms with high diagnostic accuracy [15]. This evidence concerns the gene KRT19 and benign thyroid gland neoplasm.